These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 24369274)
41. Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study. Biering-Sørensen T; Biering-Sørensen SR; Olsen FJ; Sengeløv M; Jørgensen PG; Mogelvang R; Shah AM; Jensen JS Circ Cardiovasc Imaging; 2017 Mar; 10(3):. PubMed ID: 28264868 [TBL] [Abstract][Full Text] [Related]
42. Inverse association of pulse pressure augmentation during exercise with heart failure and death. Al Rifai M; Blaha MJ; Rahman F; Ehrman JK; Brawner CA; Keteyian SJ; Al-Mallah MH; McEvoy JW Heart; 2019 Apr; 105(8):639-644. PubMed ID: 30361271 [TBL] [Abstract][Full Text] [Related]
43. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Flack JM; Neaton J; Grimm R; Shih J; Cutler J; Ensrud K; MacMahon S Circulation; 1995 Nov; 92(9):2437-45. PubMed ID: 7586343 [TBL] [Abstract][Full Text] [Related]
44. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916 [TBL] [Abstract][Full Text] [Related]
45. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry. Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683 [TBL] [Abstract][Full Text] [Related]
46. Trends in death attributed to myocardial infarction, heart failure and pulmonary embolism in Europe and Canada over the last decade. Laribi S; Aouba A; Resche-Rigon M; Johansen H; Eb M; Peacock FW; Masip J; Ezekowitz JA; Cohen-Solal A; Jougla E; Plaisance P; Mebazaa A QJM; 2014 Oct; 107(10):813-20. PubMed ID: 24729266 [TBL] [Abstract][Full Text] [Related]
47. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428 [TBL] [Abstract][Full Text] [Related]
48. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Hu G; Jousilahti P; Qiao Q; Katoh S; Tuomilehto J Diabetologia; 2005 May; 48(5):856-61. PubMed ID: 15827741 [TBL] [Abstract][Full Text] [Related]
49. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916 [TBL] [Abstract][Full Text] [Related]
51. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. Suleiman M; Khatib R; Agmon Y; Mahamid R; Boulos M; Kapeliovich M; Levy Y; Beyar R; Markiewicz W; Hammerman H; Aronson D J Am Coll Cardiol; 2006 Mar; 47(5):962-8. PubMed ID: 16516078 [TBL] [Abstract][Full Text] [Related]
52. Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme. Badar AA; Perez-Moreno AC; Hawkins NM; Brunton AP; Jhund PS; Wong CM; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Gardner RS; Petrie MC; McMurray JJ Eur J Heart Fail; 2015 Feb; 17(2):196-204. PubMed ID: 25678097 [TBL] [Abstract][Full Text] [Related]
53. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure]. Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256 [TBL] [Abstract][Full Text] [Related]
54. Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project. Sulo G; Igland J; Vollset SE; Nygård O; Ebbing M; Sulo E; Egeland GM; Tell GS J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26744379 [TBL] [Abstract][Full Text] [Related]
55. Nationwide trends in development of heart failure and mortality after first-time myocardial infarction 1997-2010: A Danish cohort study. Gjesing A; Gislason GH; Køber L; Gustav Smith J; Christensen SB; Gustafsson F; Olsen AM; Torp-Pedersen C; Andersson C Eur J Intern Med; 2014 Oct; 25(8):731-8. PubMed ID: 25225051 [TBL] [Abstract][Full Text] [Related]
56. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology. Zafrir B; Salman N; Crespo-Leiro MG; Anker SD; Coats AJ; Ferrari R; Filippatos G; Maggioni AP; Mebazaa A; Piepoli MF; Ruschitzka F; Paniagua-Martin MJ; Segovia J; Laroche C; Amir O; Eur J Heart Fail; 2016 Jul; 18(7):859-68. PubMed ID: 27198159 [TBL] [Abstract][Full Text] [Related]
57. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. Ersbøll M; Valeur N; Mogensen UM; Andersen MJ; Møller JE; Velazquez EJ; Hassager C; Søgaard P; Køber L J Am Coll Cardiol; 2013 Jun; 61(23):2365-73. PubMed ID: 23563128 [TBL] [Abstract][Full Text] [Related]
58. Sex-Related 30-Day and Long-Term Mortality in Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention. Kanic V; Vollrath M; Tapajner A; Sinkovic A J Womens Health (Larchmt); 2017 Apr; 26(4):374-379. PubMed ID: 28355097 [TBL] [Abstract][Full Text] [Related]
59. Prognostic use of echocardiography 1 year after a myocardial infarction. Skali H; Zornoff LA; Pfeffer MA; Arnold MO; Lamas GA; Moyé LA; Plappert T; Rouleau JL; Sussex BA; St John Sutton M; Braunwald E; Solomon SD; Am Heart J; 2005 Oct; 150(4):743-9. PubMed ID: 16209977 [TBL] [Abstract][Full Text] [Related]
60. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death. McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]